Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0LDR stock hub

LON/0LDR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0LDRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

960.4M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0LDR

In the news

Latest news · LON/0LDR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-12.4

P25 -54.2P50 2.1P75 13.7

ROIC-3.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0LDR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

192

Groups with data

Currency

USD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	5,600
Employees Change	100%
Employees Change Percent	1.82
Enterprise value	$1.2B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US87918A1051
Last refreshed	2026-05-10
Market cap	$960.4M
Price	$6.96
Price currency	USD
Rev Per Employee	371,625.26x
Sector	Healthcare
Sic	8090
Symbol	lon/0LDR
Website	https://www.teladochealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-13.49%
EV Earnings	-9.04x
EV/EBITDA	26.18x
EV/FCF	5.52x
EV/Sales	0.63x
FCF yield	22.09%
P/B ratio	0.95x
P/S ratio	0.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-6.25%
EBITDA Margin	1.89%
FCF margin	11.14%
Gross margin	69.29%
Gross Profit	$1.3B
Gross Profit Growth	-3.17%
Gross Profit Growth Q	-3.75%
Gross Profit Growth3 Y	0.36%
Gross Profit Growth5 Y	14.06%
Net Income	$-129.6M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-7.36%
Profit Margin	-6.81%
Profit Per Employee	$-25,295
ROA	-3.14
Roa5y	-2.32
ROCE	-6.54
ROE	-12.39
Roe5y	-45.49
ROIC	-3.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	3.11%
Cagr3y	-35.69%
Cagr5y	-45.89%
EPS Growth Quarters	2
EPS Growth Years	1
FCF Growth	-2.84%
FCF Growth Q	-40.45%
FCF Growth3 Y	8.51%
OCF Growth	-4.23%
OCF Growth Q	-40.22%
OCF Growth3 Y	7.13%
Revenue Growth	-1.5x
Revenue Growth Q	-2.47x
Revenue Growth Years	0x
Revenue Growth3 Y	0.59x
Revenue Growth5 Y	12.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.8
Assets	$2.1B
Cash	$568.5M
Current Assets	$830.6M
Current Liabilities	$297M
Debt	$786.1M
Debt EBITDA	$17.03
Debt Equity	$0.78
Debt FCF	$3.71
Equity	$1B
Interest Coverage	-8.14
Liabilities	$1.1B
Long Term Assets	$1.3B
Long Term Liabilities	$817M
Net Cash	$-217.6M
Net Cash By Market Cap	$-22.65
Net Debt EBITDA	$6.05
Net Debt Equity	$0.22
Net Debt FCF	$1.03
Tangible Book Value	$-137.9M
Tangible Book Value Per Share	$-0.76
WACC	9.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.8
Inventory Turnover	22.2
Net Working Capital	$-9.7M
Quick ratio	2.4
Working Capital	$550.9M
Working Capital Turnover	$2.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	3.11%
200-day SMA	6.86
3Y total return	-73.41%
50-day SMA	5.61
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.36%
All Time High	307.6
All Time High Change	-97.74%
All Time High Date	2021-02-16
All Time Low	4.44
All Time Low Change	56.93%
All Time Low Date	2026-02-12
ATR	0.37
Beta	2.08
Ch YTD	-0.14
High	7.38
High52	9.88
High52 Date	2025-10-27
High52ch	-29.55%
Low	6.8
Low52	4.44
Low52 Date	2026-02-12
Low52ch	56.93%
Ma50ch	24.09%
Price vs 200-day SMA	1.41%
RSI	78.3
RSI Monthly	38.37
RSI Weekly	59.34
Sharpe ratio	0.22x
Sortino ratio	0.45
Total Return	-3.08%
Tr YTD	-0.14
Tr1m	31.57%
Tr1w	7.24%
Tr3m	38.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-119M
Operating margin	-6.25

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	179,223,230%
Net Borrowing	-403,894,080.3
Shares Insiders	0.71%
Shares Institutions	74.29%
Shares Qo Q	0.73%
Shares Yo Y	3.08%
Short Ratio	5.3

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$159.2M
Average Volume	28,932.4x
Bv Per Share	5.61
CAPEX	$-5.9M
Ch1m	31.57
Ch1w	7.24
Ch1y	3.11
Ch3m	38.92
Ch3y	-73.41
Ch5y	-95.36
Ch6m	-6.35
Change	0.43%
Change From Open	-3.6
Close	6.93
Days Gap	4.18
Depreciation Amortization	150,148,848.8
Dollar Volume	415,198.8
Earnings Date	2026-04-29
EBIT	$-119M
EBITDA	$36M
EPS	$-0.73
F Score	4
FCF	$212.1M
FCF EV Yield	18.11x
Financing CF	-420,205,825
Fiscal Year End	December
Founded	2,002
Goodwill	207,723,829.7
Income Tax	$-10.6M
Investing CF	-135,752,222
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Ma150	6.59
Ma150ch	5.6%
Ma20	6.06
Ma20ch	14.87%
Net CF	-335,178,649
Next Earnings Date	2026-07-28
Open	7.22
P FCF Ratio	4.53
P OCF Ratio	4.4
Position In Range	27.59
Ppne	37,050,525.7
Price Date	2026-05-08
Price EBITDA	$26.69
Relative Volume	3.08x
Revenue	1,904,207,829x
SBC By Revenue	2.78x
Share Based Comp	52,906,842
Tax By Revenue	-0.56x
Tr6m	-6.35%
Volume	59,655
Z Score	-6.69

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0LDR pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0LDR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0LDR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+74.3%

Share of float held by funds and institutions

Insider ownership

+0.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0LDR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

78.3

Above 70: short-term overbought

Price vs 200-day MA

+1.4%

50/200-day relationship not available

Beta (5Y)

2.08

More volatile than the market

Sharpe ratio

0.22

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0LDR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0LDR stock rating?

lon/0LDR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0LDR analysis?

The full report lives at /stocks/lon/0LDR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0LDR?

The latest report frames lon/0LDR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0LDR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.